PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#ointment ×

UPDATED
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA Discontinues FLUTEX Topical Ointment (ANDA087377)
FDA records indicate the FLUTEX topical ointment (0.1% Triamcinolone Acetoinide) by IVAX PHARMS is discontinued, with original ANDA approval in 1988 and a labeling supplement in 1992.
1
UPDATED
Regulatorische Updates
27. Aug. 2026•1 Min. Lesezeit
FDA Announces Discontinued Ophthalmic Ointment DEXAIR (ANDA088071)
The FDA’s ANDA088071 filing shows that DEXAIR ophthalmic ointment, containing 0.05% dexamethasone sodium phosphate, is marked discontinued by sponsor PharmaFair.